K. V. Levandowska. IMPROVING THE USE OF MYOCARDIAL CYTOPROTECTORS AS A METABOLIC THERAPY OF PATIENTS WITH DECOMPENSATED HEART FAILURE IN THE EARLY AND LATE POST-INFARCE PERIOD. pulse 2022, 69-83.